There are several molecules which are used in the treatment of diabetes mellitus. The treatment of diabetes mellitus is often dependent on the goals of the treatment. This article provides a basic information about albiglutide, a GLP-1 agonist used as an adjunct therapy for Type 2 diabetes mellitus. Albiglutide is a Glucagon-like Peptide-1 (GLP-1) agonist used for the treatment of type 2 diabetes mellitus (T2DM) as an adjunct therapy with diet and exercise.
Albiglutide has a half-life longer than other two GLP-1 analogs namely exenatide and liraglutide. Albiglutide is an agonist of human glucagon-like peptide-1 (GLP-1) receptor and augments glucose-dependent insulin secretion and slows gastric emptying. The drug is administered subcutaneously with the injection or pen. Due to its extended half-life, albiglutide is injected only weekly or biweekly to achieve glycemic control which makes…
